Home Overview Press Room Blog Publications For Students about us
Search

Pete Shanks's Blog Posts


Pete Shanks, MA, attended Oxford University, where he studied Philosophy, Politics and Economics, and moved to California in the mid-1970s. He has been active in a range of local and international political movements, while mostly making his living in the publishing industry, especially on the production side; he enjoys the craft of bookmaking. Appalled by the eugenic possibilities of biotechnology, he has worked with the Center for Genetics and Society since its earliest days. He is the author of Human Genetic Engineering: A Guide for Activists, Skeptics, and the Very Perplexed (Nation Books) and a regular contributor to Biopolitical Times.

Patently Absurd? Or Absurdly Patentable?by Pete ShanksBiopolitical TimesNovember 12th, 2014The US Supreme Court might agree to rule on the validity of stem-cell patents, and the Canadian courts are being asked to invalidate a patent on disease-linked genes.
Are All Pluripotent Stem Cells Equal?by Pete ShanksBiopolitical TimesNovember 12th, 2014A new paper by long-term advocates of research cloning implies that it has no advantage over reprogramming cells.
Let's Play God (or not)by Pete ShanksBiopolitical TimesOctober 14th, 2014Reason magazine earns points for honesty about wanting to use gene drives to "play God" — and for editing skills.
Hwang Woo-suk Reaches the Silver Screenby Pete ShanksBiopolitical TimesOctober 2nd, 2014A new movie opening in Korea is explicitly about how the notorious cloning and stem-cell fraud was revealed, though the names of the principals have been changed.
Synthetic Biology Is What, Exactly?by Pete ShanksBiopolitical TimesOctober 1st, 2014The European Commission is the latest body to struggle with defining the term synthetic biology, and has produced a 65-page report.
Drew Endy's Hollywood Dreams for Synthetic Biologyby Pete ShanksBiopolitical TimesSeptember 18th, 2014Stanford professor Drew Endy is convinced that this is the century of biology, and in particular of making things with biology, but is concerned that popular media do not seem to reflect this.
Shame and Scandal in the 23andMe Familyby Pete ShanksBiopolitical TimesSeptember 17th, 2014In response to its problems with the FDA and news about family traumas triggered by its tests' "close relatives" option, 23andMe is hiring new executives, including a Chief Privacy Officer.
“Evolution right now is in the marketplace”by Pete ShanksBiopolitical TimesSeptember 11th, 2014George Church is as outrageous as ever, while both transhumanist ideas and concerns about increasing inequality are receiving more attention.
"3-Person IVF" Debated in UK Parliamentby Pete ShanksBiopolitical TimesSeptember 3rd, 2014The debate in Britain over combining eggs or embryos to prevent the transmission of mitochondrial disease received a public airing, though no firm conclusion, in the House of Commons on September 1st.
Moving on from Nicholas Wade to Continuing Concerns about Scientific Racismby Pete ShanksBiopolitical TimesAugust 14th, 2014Over 140 geneticists publicly criticized Nicholas Wade for distorting their work; but that is unlikely to stop such abuse permanently, and many issues still deserve airing.
Data Yearning to Become Expensive Informationby Pete ShanksBiopolitical TimesAugust 6th, 2014Big players have big “big data and genetics” plans afoot. Here’s the news from Genomics England, 23andMe, Google and Craig Venter.
Failures and Risks in Biosafety Regulationby Pete ShanksBiopolitical TimesJuly 24th, 2014Accidents at CDC and elsewhere point up the difficulties in regulating potentially dangerous releases of genetically modified organisms, which scientists are, quite responsibly, discussing.
Shameful Conflicts of Interest Involving California's Stem Cell Agencyby Pete ShanksBiopolitical TimesJuly 9th, 2014The former President of CIRM just took a job on the board of a company that benefited from the agency's grants, highlighting the conflicts of interest that have always bedeviled the agency.
On Meta-Research and the STAP Fiascoby Pete ShanksBiopolitical TimesJuly 7th, 2014The authors of the ballyhooed STAP papers have reluctantly agreed to retract them; meanwhile Stanford is launching a project to investigate the process of research.
Implications of Genetic Diversity in Mexicoby Pete ShanksBiopolitical TimesJune 25th, 2014Two genomic surveys, one of Mexicans and one of self-identified Latinos, raise questions about the scientific use of cultural terms, and also hold implications for personalized medicine.
Selling Stem Cells Honestlyby Pete ShanksBiopolitical TimesJune 25th, 2014Scientists around the world are campaigning in favor of sensible regulation of stem-cell therapies. It’s about time.
When and How Will We Regulate Synthetic Biology?by Pete ShanksBiopolitical TimesJune 6th, 2014Several discussion documents about potential ways to regulate synthetic biology, nationally and internationally, have recently been published. They range from serious efforts to industry public relations exercises.
Wading into Racismby Pete ShanksBiopolitical TimesJune 6th, 2014A Troublesome Inheritance: Genes, Race and Human History has been out for a month, and the fuss, such as it was, seems to be dying down, but the underlying issues remain significant.
2-4-6-8, Novel Pairs to Replicateby Pete ShanksBiopolitical TimesMay 29th, 2014A pair of artificial nucleotides have been inserted into E. coli, which reproduced the three base-pairs successfully until the source of nucleotides ran out.
Stem Cells in Sports Medicineby Pete ShanksBiopolitical TimesMay 29th, 2014The use of adult stem cells in sports medicine is growing, although the evidence that they help post-operative recovery is anecdotal.
Displaying 1-20 of 277  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760